癌胎児性抗原（CEA）の世界市場（～2026年）

• 英文タイトル：Global Carcinoembryonic Antigen (CEA) Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY11253 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は癌胎児性抗原（CEA）のグローバル市場について調査・分析したレポートです。種類別（CD66a、CD66b、CD66c、CD66d、CD66e、CD66f）市場規模、用途別（大腸がん、膵臓がん、卵巣がん、乳がん、甲状腺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別癌胎児性抗原（CEA）の競争状況、市場シェア ・世界の癌胎児性抗原（CEA）市場：種類別市場規模 2015年-2020年（CD66a、CD66b、CD66c、CD66d、CD66e、CD66f） ・世界の癌胎児性抗原（CEA）市場：種類別市場規模予測 2021年-2026年（CD66a、CD66b、CD66c、CD66d、CD66e、CD66f） ・世界の癌胎児性抗原（CEA）市場：用途別市場規模 2015年-2020年（大腸がん、膵臓がん、卵巣がん、乳がん、甲状腺がん、その他） ・世界の癌胎児性抗原（CEA）市場：用途別市場規模予測 2021年-2026年（大腸がん、膵臓がん、卵巣がん、乳がん、甲状腺がん、その他） ・北米の癌胎児性抗原（CEA）市場分析：米国、カナダ ・ヨーロッパの癌胎児性抗原（CEA）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの癌胎児性抗原（CEA）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の癌胎児性抗原（CEA）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの癌胎児性抗原（CEA）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche Diagnostics、Abbott Diagnostics、Quest Diagnostics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion.
Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period.

Market Analysis and Insights: Global Carcinoembryonic Antigen (CEA) Market
The global Carcinoembryonic Antigen (CEA) market size is projected to reach US$ 1831.1 million by 2026, from US$ 1753.7 million in 2020, at a CAGR of 4.1%% during 2021-2026.

Global Carcinoembryonic Antigen (CEA) Scope and Market Size
Carcinoembryonic Antigen (CEA) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Carcinoembryonic Antigen (CEA) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics
…

Market segment by Type, the product can be split into
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
Market segment by Application, split into
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Carcinoembryonic Antigen (CEA) Revenue
1.4 Market by Type
1.4.1 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 CD66a
1.4.3 CD66b
1.4.4 CD66c
1.4.5 CD66d
1.4.6 CD66e
1.4.7 CD66f
1.5 Market by Application
1.5.1 Global Carcinoembryonic Antigen (CEA) Market Share by Application: 2020 VS 2026
1.5.2 Colorectal Cancer
1.5.3 Pancreatic Cancer
1.5.4 Ovarian Cancer
1.5.5 Breast Cancer
1.5.6 Thyroid Cancer
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Carcinoembryonic Antigen (CEA) Market Perspective (2015-2026)
2.2 Global Carcinoembryonic Antigen (CEA) Growth Trends by Regions
2.2.1 Carcinoembryonic Antigen (CEA) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Carcinoembryonic Antigen (CEA) Historic Market Share by Regions (2015-2020)
2.2.3 Carcinoembryonic Antigen (CEA) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Carcinoembryonic Antigen (CEA) Market Growth Strategy
2.3.6 Primary Interviews with Key Carcinoembryonic Antigen (CEA) Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Carcinoembryonic Antigen (CEA) Players by Market Size
3.1.1 Global Top Carcinoembryonic Antigen (CEA) Players by Revenue (2015-2020)
3.1.2 Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Players (2015-2020)
3.1.3 Global Carcinoembryonic Antigen (CEA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio
3.2.1 Global Carcinoembryonic Antigen (CEA) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Carcinoembryonic Antigen (CEA) Revenue in 2019
3.3 Carcinoembryonic Antigen (CEA) Key Players Head office and Area Served
3.4 Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
3.5 Date of Enter into Carcinoembryonic Antigen (CEA) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Type (2015-2020)
4.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)
5.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
6.2 Carcinoembryonic Antigen (CEA) Key Players in North America (2019-2020)
6.3 North America Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
6.4 North America Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)

7 Europe
7.1 Europe Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
7.2 Carcinoembryonic Antigen (CEA) Key Players in Europe (2019-2020)
7.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
7.4 Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)

8 China
8.1 China Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
8.2 Carcinoembryonic Antigen (CEA) Key Players in China (2019-2020)
8.3 China Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
8.4 China Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)

9 Japan
9.1 Japan Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
9.2 Carcinoembryonic Antigen (CEA) Key Players in Japan (2019-2020)
9.3 Japan Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
9.4 Japan Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
10.2 Carcinoembryonic Antigen (CEA) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
10.4 Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)

11 India
11.1 India Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
11.2 Carcinoembryonic Antigen (CEA) Key Players in India (2019-2020)
11.3 India Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
11.4 India Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Carcinoembryonic Antigen (CEA) Market Size (2015-2020)
12.2 Carcinoembryonic Antigen (CEA) Key Players in Central & South America (2019-2020)
12.3 Central & South America Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020)
12.4 Central & South America Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Roche Diagnostics
13.1.1 Roche Diagnostics Company Details
13.1.2 Roche Diagnostics Business Overview
13.1.3 Roche Diagnostics Carcinoembryonic Antigen (CEA) Introduction
13.1.4 Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020))
13.1.5 Roche Diagnostics Recent Development
13.2 Abbott Diagnostics
13.2.1 Abbott Diagnostics Company Details
13.2.2 Abbott Diagnostics Business Overview
13.2.3 Abbott Diagnostics Carcinoembryonic Antigen (CEA) Introduction
13.2.4 Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020)
13.2.5 Abbott Diagnostics Recent Development
13.3 Quest Diagnostics
13.3.1 Quest Diagnostics Company Details
13.3.2 Quest Diagnostics Business Overview
13.3.3 Quest Diagnostics Carcinoembryonic Antigen (CEA) Introduction
13.3.4 Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020)
13.3.5 Quest Diagnostics Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Carcinoembryonic Antigen (CEA) Key Market Segments
Table 2. Key Players Covered: Ranking by Carcinoembryonic Antigen (CEA) Revenue
Table 3. Ranking of Global Top Carcinoembryonic Antigen (CEA) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of CD66a
Table 6. Key Players of CD66b
Table 7. Key Players of CD66c
Table 8. Key Players of CD66d
Table 9. Key Players of CD66e
Table 10. Key Players of CD66f
Table 11. Global Carcinoembryonic Antigen (CEA) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Carcinoembryonic Antigen (CEA) Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Carcinoembryonic Antigen (CEA) Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Carcinoembryonic Antigen (CEA) Market Share by Regions (2015-2020)
Table 15. Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Carcinoembryonic Antigen (CEA) Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Carcinoembryonic Antigen (CEA) Market Growth Strategy
Table 21. Main Points Interviewed from Key Carcinoembryonic Antigen (CEA) Players
Table 22. Global Carcinoembryonic Antigen (CEA) Revenue by Players (2015-2020) (Million US$)
Table 23. Global Carcinoembryonic Antigen (CEA) Market Share by Players (2015-2020)
Table 24. Global Top Carcinoembryonic Antigen (CEA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoembryonic Antigen (CEA) as of 2019)
Table 25. Global Carcinoembryonic Antigen (CEA) by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
Table 28. Date of Enter into Carcinoembryonic Antigen (CEA) Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (Million US$)
Table 31. Global Carcinoembryonic Antigen (CEA) Market Size Share by Type (2015-2020)
Table 32. Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Type (2021-2026)
Table 33. Global Carcinoembryonic Antigen (CEA) Market Size Share by Application (2015-2020)
Table 34. Global Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (Million US$)
Table 35. Global Carcinoembryonic Antigen (CEA) Market Size Share by Application (2021-2026)
Table 36. North America Key Players Carcinoembryonic Antigen (CEA) Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Carcinoembryonic Antigen (CEA) Market Share (2019-2020)
Table 38. North America Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (Million US$)
Table 39. North America Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 40. North America Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (Million US$)
Table 41. North America Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 42. Europe Key Players Carcinoembryonic Antigen (CEA) Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Carcinoembryonic Antigen (CEA) Market Share (2019-2020)
Table 44. Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 46. Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 48. China Key Players Carcinoembryonic Antigen (CEA) Revenue (2019-2020) (Million US$)
Table 49. China Key Players Carcinoembryonic Antigen (CEA) Market Share (2019-2020)
Table 50. China Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (Million US$)
Table 51. China Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 52. China Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (Million US$)
Table 53. China Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 54. Japan Key Players Carcinoembryonic Antigen (CEA) Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Carcinoembryonic Antigen (CEA) Market Share (2019-2020)
Table 56. Japan Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 58. Japan Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Carcinoembryonic Antigen (CEA) Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Carcinoembryonic Antigen (CEA) Market Share (2019-2020)
Table 62. Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 64. Southeast Asia Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 66. India Key Players Carcinoembryonic Antigen (CEA) Revenue (2019-2020) (Million US$)
Table 67. India Key Players Carcinoembryonic Antigen (CEA) Market Share (2019-2020)
Table 68. India Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (Million US$)
Table 69. India Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 70. India Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (Million US$)
Table 71. India Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Carcinoembryonic Antigen (CEA) Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Carcinoembryonic Antigen (CEA) Market Share (2019-2020)
Table 74. Central & South America Carcinoembryonic Antigen (CEA) Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Carcinoembryonic Antigen (CEA) Market Share by Type (2015-2020)
Table 76. Central & South America Carcinoembryonic Antigen (CEA) Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Carcinoembryonic Antigen (CEA) Market Share by Application (2015-2020)
Table 78. Roche Diagnostics Company Details
Table 79. Roche Diagnostics Business Overview
Table 80. Roche Diagnostics Product
Table 81. Roche Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020) (Million US$)
Table 82. Roche Diagnostics Recent Development
Table 83. Abbott Diagnostics Company Details
Table 84. Abbott Diagnostics Business Overview
Table 85. Abbott Diagnostics Product
Table 86. Abbott Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020) (Million US$)
Table 87. Abbott Diagnostics Recent Development
Table 88. Quest Diagnostics Company Details
Table 89. Quest Diagnostics Business Overview
Table 90. Quest Diagnostics Product
Table 91. Quest Diagnostics Revenue in Carcinoembryonic Antigen (CEA) Business (2015-2020) (Million US$)
Table 92. Quest Diagnostics Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Carcinoembryonic Antigen (CEA) Market Share by Type: 2020 VS 2026
Figure 2. CD66a Features
Figure 3. CD66b Features
Figure 4. CD66c Features
Figure 5. CD66d Features
Figure 6. CD66e Features
Figure 7. CD66f Features
Figure 8. Global Carcinoembryonic Antigen (CEA) Market Share by Application: 2020 VS 2026
Figure 9. Colorectal Cancer Case Studies
Figure 10. Pancreatic Cancer Case Studies
Figure 11. Ovarian Cancer Case Studies
Figure 12. Breast Cancer Case Studies
Figure 13. Thyroid Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Carcinoembryonic Antigen (CEA) Report Years Considered
Figure 16. Global Carcinoembryonic Antigen (CEA) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Carcinoembryonic Antigen (CEA) Market Share by Regions: 2020 VS 2026
Figure 18. Global Carcinoembryonic Antigen (CEA) Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Carcinoembryonic Antigen (CEA) Market Share by Players in 2019
Figure 21. Global Top Carcinoembryonic Antigen (CEA) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Carcinoembryonic Antigen (CEA) as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Carcinoembryonic Antigen (CEA) Revenue in 2019
Figure 23. North America Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Carcinoembryonic Antigen (CEA) Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed

---